Aymanshafei (Talk | contribs) |
Aymanshafei (Talk | contribs) |
||
Line 178: | Line 178: | ||
<div class="col-sm-4 text-center"> | <div class="col-sm-4 text-center"> | ||
<div class="social-icon"> | <div class="social-icon"> | ||
− | <a href="www.facebook.com"> | + | <a href=" https://www.facebook.com/igem.egy"> |
<div class="icon fb"> | <div class="icon fb"> | ||
<i class="fa fa-facebook"></i> | <i class="fa fa-facebook"></i> | ||
Line 185: | Line 185: | ||
<a href="www.twitter.com"> | <a href="www.twitter.com"> | ||
<div class="icon twitter"> | <div class="icon twitter"> | ||
− | <i class=" | + | <i class="fa fa-facebook"></i> |
</div> | </div> | ||
</a> | </a> |
Revision as of 17:09, 16 October 2017
Abstract
Knock-in of Circular RNA gene in Hepatocellular Carcinoma cells via CRISPR/Cas9
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers
in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-.
"Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique
that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma.
This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials.
This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt - based upon results of National Cancer Registry Program of Egypt-. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.